Science Explorer Interactive view Map
Company · Künzelsau · Germany

Würth (Germany)

wuerth.com/web/de/wuerthcom/portal/portalseite.phpROR OpenAlex
World rank, all time
#38,322
of 42,892
Rank in Germany
#1,841
of 2,077
Research works
148
▼ 17% vs 2013–17
Citations
598
4.0 per fractional work
Top-10% rate
1.8%
record average 16.5%
Open access
19%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.42× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.67× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 2.00× its world share, 1 worksImmunology and Micro…Neuroscience: 0.53× its world share, 0 worksNeuroscienceChemistry: 0.18× its world share, 0 worksChemistryComputer Science: 0.48× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.73× its world share, 1 worksEarth and Planetary …Engineering: 0.28× its world share, 2 worksEngineeringEnvironmental Science: 0.23× its world share, 1 worksEnvironmental ScienceHealth Professions: 0.44× its world share, 1 worksHealth ProfessionsMedicine: 3.06× its world share, 34 worksMedicineArts and Humanities: 1.70× its world share, 3 worksArts and HumanitiesBusiness, Management and Accounting: 0.57× its world share, 1 worksBusiness, Management…Economics, Econometrics and Finance: 0.99× its world share, 1 worksEconomics, Econometr…Psychology: 0.33× its world share, 1 worksPsychologySocial Sciences: 0.44× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.1×. Every wedge is a field page.

Which keywords describe research at Würth (Germany)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Breast Cancer, Trastuzumab, Clinical Practice Guidelines, Radiation Therapy, Survival Analysis, Metastatic Breast Cancer and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy9▲ 23×7 topics
  2. Breast Cancer8▲ 61×6 topics
  3. Trastuzumab5▲ 184×2 topics
  4. Clinical Practice Guidelines4▲ 14×3 topics
  5. Radiation Therapy4▲ 53×2 topics
  6. Survival Analysis4▲ 25×2 topics
  7. Immunotherapy3▲ 8.1×6 topics
  8. Metastatic Breast Cancer3▲ 102×2 topics
  9. Metastatic3▲ 88×2 topics
  10. Neoadjuvant Therapy3▲ 23×2 topics
  11. Biopsy3▲ 85×2 topics
  12. Clinical Trials3▲ 7.7×3 topics
  13. EGFR3▲ 172×1 topic
  14. HER23▲ 172×1 topic
  15. Quality of Life3▲ 3.4×6 topics
  16. Metastasis2▲ 13×2 topics
  17. Radiotherapy2▲ 11×3 topics
  18. Robotic Surgery2▲ 30×2 topics
  19. Biomarkers2▲ 5.9×2 topics
  20. Prevention2▲ 9.6×2 topics
  21. Prostate Cancer2▲ 31×2 topics
  22. Cervical Cancer2▲ 36×1 topic
  23. Clinical Guidelines2▲ 13×2 topics
  24. Endometrial Carcinoma2▲ 94×1 topic
  25. Prognostic Markers2▲ 35×2 topics
  26. Screening2▲ 40×2 topics
  27. Anthracyclines2▲ 204×1 topic
  28. Doxorubicin2▲ 204×1 topic
  29. Molecular Characterization2▲ 19×3 topics
  30. Breast Tumours2▲ 68×1 topic
  31. CDK4/6 Inhibitors2▲ 127×1 topic
  32. Gene Expression2▲ 5.2×1 topic
  33. Genomic Analysis2▲ 13×1 topic
  34. Gleason Grading2▲ 80×1 topic
  35. MRI Imaging2▲ 38×1 topic
  36. Ovarian Cancer2▲ 36×1 topic
  37. Palbociclib2▲ 127×1 topic
  38. Estrogen2▲ 77×1 topic
  39. Receptor2▲ 90×1 topic
  40. Chemotherapy-Induced Peripheral Neuropathy2▲ 82×1 topic

Which research topics does Würth (Germany) publish most on?

By volume in 2022–2025: HER2/EGFR in Cancer Research, Endometrial and Cervical Cancer Treatments, Chemotherapy-induced cardiotoxicity and mitigation and Advanced Breast Cancer Therapies.

HER2/EGFR in Cancer Rese…3HER2/EGFR in Cancer Research: 3 fractional worksEndometrial and Cervical…2Endometrial and Cervical Cancer Treatments: 2 fractional worksChemotherapy-induced cardiotoxicity and mitigation: 2 fractional worksAdvanced Breast Cancer Therapies: 2 fractional worksProstate Cancer Diagnosis and Treatment: 2 fractional worksOvarian cancer diagnosis and treatment: 2 fractional worksBreast Cancer Treatment Studies: 2 fractional worksEstrogen and related hor…2Estrogen and related hormone effects: 2 fractional worksCancer Treatment and Pharmacology: 2 fractional worksBladder and Urothelial Cancer Treatments: 1 fractional works
OncologyObstetrics and GynecologyCardiology and Cardiovascular MedicinePulmonary and Respiratory Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HER2/EGFR in Cancer Research Oncology 3 works
  2. 2 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 2 works
  3. 3 Chemotherapy-induced cardiotoxicity and mitigation Cardiology and Cardiovascular Medicine 2 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  5. 5 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
  6. 6 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
  7. 7 Breast Cancer Treatment Studies Cancer Research 2 works
  8. 8 Estrogen and related hormone effects Genetics 2 works
  9. 9 Cancer Treatment and Pharmacology Oncology 2 works
  10. 10 Bladder and Urothelial Cancer Treatments Surgery 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available19.4%not open80.6%

World: 28% of research is openly available.

with international co-authors11.1%domestic only88.9%

World: 19% is written across borders.

How has Würth (Germany)'s research output changed?

Output in 2018–2022 was 17% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.